These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 5742340)

  • 21. [Properties of phase I purified cellular antigen of Coxiella burnetii].
    Kruszewska D; Rumin W; Tylewska-Wierzbanowska S
    Med Dosw Mikrobiol; 1989; 41(3-4):170-5. PubMed ID: 2484257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II to phase I conversion of Coxiella burneti in immunosuppressed mice.
    Kazár J; Brezina R; Skultétyová E; Kovácová E; Schramek S
    Acta Virol; 1975 Jul; 19(4):359-63. PubMed ID: 241236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. THE INFLUENCE OF PHASE ON THE PROTECTIVE POTENCY OF Q FEVER VACCINE.
    ORMSBEE RA; BELL EJ; LACKMAN DB; TALLENT G
    J Immunol; 1964 Mar; 92():404-12. PubMed ID: 14128986
    [No Abstract]   [Full Text] [Related]  

  • 24. Local pathogenic effects of Q fever vaccines. Some attempts to diminish the local pathogenic effect of phase I Coxiella burneti corpuscular vaccine.
    Crăcea E; Zarnea G; Dumitrescu S; Botez D; Sabin S
    Arch Roum Pathol Exp Microbiol; 1972 Sep; 31(3):367-72. PubMed ID: 4665073
    [No Abstract]   [Full Text] [Related]  

  • 25. Vaccination of cattle against Q-fever.
    Sádecký E; Brezina R; Michalovic M
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(2):200-6. PubMed ID: 1236883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electron microscopic study in guinea-pig cells during infection or vaccination with Coxiella burneti.
    Dumitrescu S; Ionescu MD; Crăcea E; Petrovici A; Botez D; Ioanid L
    Arch Roum Pathol Exp Microbiol; 1975; 34(1-2):145-53. PubMed ID: 1212070
    [No Abstract]   [Full Text] [Related]  

  • 27. Onset and duration of immunity in guinea pigs and mice induced with different Q fever vaccines.
    Kazár J; Votruba D; Propper P; Schramek S
    Acta Virol; 1986 Nov; 30(6):499-506. PubMed ID: 2881470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of antibody response and immunoglobulins in sera of rabbits and guinea pigs immunized with Coxiella burnetii.
    Kazár J; Schramek S; Brezina R
    Acta Virol; 1977 May; 21(3):246-55. PubMed ID: 18924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The significance of the complement fixation test with antigen from phase I Rickettsia burneti in the diagnosis of Q fever].
    Fedorova NI; Kudelina RI; Diuĭsalieva RG; Vorontsova TA; Rozhechenko LM; Gabrieliants ER
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Sep; 44(9):44-9. PubMed ID: 5615963
    [No Abstract]   [Full Text] [Related]  

  • 30. Preparation of phase 1Q fever antigen suitable for vaccine use.
    Spicer DS; DeSanctis AN
    Appl Environ Microbiol; 1976 Jul; 32(1):85-8. PubMed ID: 970938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The soluble fraction of Rickettsia burneti, its extraction and antigenic properties].
    Kudelina RI
    Zh Mikrobiol Epidemiol Immunobiol; 1969 May; 46(5):9-13. PubMed ID: 5799608
    [No Abstract]   [Full Text] [Related]  

  • 32. Q fever: antigens and vaccines.
    Lancet; 1984 Dec; 2(8417-8418):1435-6. PubMed ID: 6151048
    [No Abstract]   [Full Text] [Related]  

  • 33. [Attenuated variants of Rickettsia burneti and several prospects for their use in live vaccines against Q fever].
    Urakov NN; Gudima OS; Tereshchenko MO; Shchetinin VP; Shevyreva NA
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Feb; 43(2):143. PubMed ID: 6004845
    [No Abstract]   [Full Text] [Related]  

  • 34. A rapid immunofluorescent procedure for serodiagnosis of Q fever in mice, guinea pigs, sheep, and humans.
    Ascher MS; Horwith GS; Thornton MF; Greenwood JR; Berman MA
    Diagn Immunol; 1983; 1(1):33-8. PubMed ID: 6388964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple method for preparation of complement-fixing Coxiella burneti antigen.
    Jusić D; Sooś E
    Acta Virol; 1968 Mar; 12(2):177-80. PubMed ID: 4384409
    [No Abstract]   [Full Text] [Related]  

  • 36. Testing in various systems of the neutralizing capacity of Q fever immune sera.
    Kazár J; Brezina R; Kovácová E; Urvölgyi J
    Acta Virol; 1973 Jan; 17(1):79-89. PubMed ID: 4119333
    [No Abstract]   [Full Text] [Related]  

  • 37. Suitability of the microagglutination test for detection of post-infection and post-vaccination Q fever antibodies in human sera.
    Kazár J; Brezina R; Schramek S; Palanová A; Tvrdá B
    Acta Virol; 1981 Jul; 25(4):235-40. PubMed ID: 6116418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new method of preparing diagnostic Q fever antigen.
    Schramek S; Brezina R; Urvölgyi J
    Acta Virol; 1972 Nov; 16(6):487-92. PubMed ID: 4404900
    [No Abstract]   [Full Text] [Related]  

  • 39. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
    Wilhelmsen CL; Waag DM
    Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dermal reactions and antibody responses in dairy cows and laboratory animals vaccinated with Coxiella burnetii.
    Biberstein EL; Crenshaw GL; Behymer DE; Franti CE; Bushnell RB; Riemann HP
    Cornell Vet; 1974 Jul; 64(3):387-406. PubMed ID: 4845729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.